The World Health Organization reports that over 890 million adults worldwide were classified as obese in 2024, a figure that has more than tripled since 1975, while the International Diabetes Federation estimates that approximately 537 million adults currently live with diabetes globally, projected to rise to 783 million by 2045
Cellular Detox & Glow: Flush out and free radicals that cause dullness and premature aging
Book a consultation today to see whether GLP-1 therapy fits your weight management goals
Approximately 15% sequence identity was found between O-class GSTs and CLIC1 [219]
Higher concentrations are not necessarily more effective GHK-Cu operates through receptor-mediated signaling rather than dose-dependent saturation
Metabolic Research Retatrutide 8mg $89 Eli Lilly's investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously demonstrating up to 28.7% weight loss in Phase 3 trials, the highest of any obesity pharmacotherapy to date
